The West Virginia State Legislature has introduced House Bill 3235, aimed at enhancing breast cancer screening coverage for women across the state. Introduced on March 7, 2025, the bill mandates that all insurance policies provide comprehensive coverage for mammograms, pap smears, and human papillomavirus (HPV) testing, aligning with guidelines from recognized health authorities.

Key provisions of the bill include requiring insurers to cover one baseline mammogram for women aged 30 to 39, annual mammograms for those aged 40 and older, and additional screenings for younger women with a family history of breast cancer or other risk factors. The legislation also stipulates that coverage for these services cannot be denied when deemed medically appropriate by licensed healthcare providers.

The bill has sparked discussions among lawmakers and health advocates, with supporters emphasizing its potential to improve early detection rates and reduce breast cancer mortality. Critics, however, have raised concerns about the financial implications for insurance companies and the potential for increased premiums.

The economic impact of House Bill 3235 could be significant, as it aims to ensure that women have access to essential preventive care without facing prohibitive costs. Socially, the bill addresses disparities in healthcare access, particularly for women at higher risk of breast cancer due to genetic factors or family history.

As the bill progresses through the legislative process, its implications for women's health in West Virginia remain a focal point of debate. If passed, it could set a precedent for similar legislation in other states, potentially reshaping the landscape of preventive healthcare coverage nationwide.